Emergent Biosolutions Inc EBS

NYS: EBS | ISIN: US29089Q1058   18/04/2024
1,860 USD (-2,11%)
(-2,11%)   18/04/2024

16 oktober 2023 · Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic · Persbericht

22 augustus 2023 · Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 · Persbericht

23 november 2021 · SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 · Persbericht

18 juni 2021 · EMERGENT BIOSOLUTIONS 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc. - EBS · Persbericht

14 juni 2021 · EBS Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors or June 18, 2021 Deadline in Securities Fraud Class Action Lawsuit · Persbericht

8 juni 2021 · Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. · Persbericht

2 juni 2021 · Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. · Persbericht

28 mei 2021 · Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Emergent BioSolutions Inc. · Persbericht

23 mei 2021 · DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Emergent BioSolutions Inc. Securities Fraud Class Action Lawsuit · Persbericht

17 mei 2021 · Kessler Topaz Meltzer & Check, LLP Files A Shareholder Class Action Lawsuit Against Emergent Biosolutions Inc. (NYSE: EBS) For Violations Of Federal Securities Laws With Expanded Class Period · Persbericht

12 mei 2021 · Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Investors of Securities Fraud Class Action Lawsuit · Persbericht

8 mei 2021 · Emergent BioSolutions Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. · Persbericht

7 mei 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS) · Persbericht

2 mei 2021 · Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. · Persbericht

27 april 2021 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO's Insider Sales · Persbericht

26 april 2021 · Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. · Persbericht

23 april 2021 · EBS Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm · Persbericht

1 maart 2021 · Emergent BioSolutions to Participate in Investor Conferences · Persbericht

4 februari 2021 · Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021 · Persbericht

10 januari 2021 · Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results · Persbericht

Mijn selecties